Marbury Partner Ben Mazahery is presenting the "Patent Year in Review" at this year's Continuing Legal Education (CLE) program hosted by the Kansas Bar Association. In addition to various other insightful topics, he will discuss the ongoing complexities of 35 U.S.C. § 101, particularly its implications for the Tech and Biotech Diagnostics sectors. Intellectual Property Law [...]
Marbury Senior Partner, Tom Irving, was thrilled to be featured on a podcast hosted by his friend, Eli Mazour, for one of the much-followed Clause 8 episodes. Unscripted, Eli covered a host of topics ranging from how Tom has helped build valuable patent portfolios for innovator pharmaceutical companies and start-ups, including several successful multi-billion dollar [...]
By Christine Norris, Michelle E. O’Brien, and Tom Irving The simple one letter word, “a” continues to spawn significant ambiguity in U.S. patent claim construction. We have seen the Federal Circuit interpret the term “a” open-endedly to leave room for plural claim elements (one or more), or as inferring a singular claim element (one). The [...]
By Michelle O’Brien, Bob Hansen, and Tom Irving The United States Patent and Trademark Office (USPTO) has issued an Advance Notice of Proposed Rulemaking (ANPRM) seeking comments on various modifications, under consideration, to the rules of practice for inter partes review (IPR) and post grant review (PGR) proceedings before the Patent Trial and Appeal Board [...]
Marbury Senior Partner Tom Irving and Partner Michelle O'Brien will be part of a distinguished panel of life sciences attorneys co-presenting a Strafford Webinar on Patenting Polymorphs: Opportunities and Challenges, discussing all aspects of patenting polymorphs from drafting through patent prosecution and enforcement. Tuesday, May 2, 2023 – 1:00pm-2:45pm EST / 10:00am-11:45am PST [...]
RESTON, VA – The Marbury Law Group, PLLC, is pleased to announce that Tom Irving, a prominent and highly-esteemed patent attorney, has joined the firm as Senior Partner, effective April 1, 2023. Tom's LinkedIn Profile Tom, whose career has spanned more than 47 years, will focus on growth opportunities for the firm, including working with [...]
Marbury Partner Michelle E. O'Brien will lead an expert panel of attorneys to discuss drafting and prosecuting patents to maximize the chances of success in obtaining a favorable Markman outcome. https://www.straffordpub.com/products/tljpkdekna?utm_campaign=tljpkdekna
Trade Secrets protect information: 1) that a business has taken reasonable measures to keep secret; and 2) that derives real or potential independent economic value from not being generally known or ascertainable. Under the Defend Trade Secrets Act, 18 U.S.C. § 1836(b), misappropriation of a trade secret occurs when a person acquires the trade secret [...]
2022 was a great year for research into advanced computing. The company OpenAI (https://openai.com) made DALL-E and ChatGTP open to the public. DALL-E generates digital images from natural language descriptions. ChatGTP is a chatbot that generates written responses to natural language queries. Both systems use a Generative Pre-trained Transformer (GPT) model, a machine learning model [...]
Marbury Partner Michelle E. O’Brien will join an expert panel of patent practitioners to discuss the latest Federal Circuit decisions concerning the Doctrine of Equivalents, with a focus on drafting and prosecuting patents to minimize estoppel-preventing DOE arguments. Tuesday, December 13th, 2022 - 1:00pm-2:30pm EST / 10:00am-11:30am PST https://www.straffordpub.com/products/doctrine-of-equivalents-in-patent-prosecution-doe-application-festo-exceptions-recent-case-law-developments-2022-12-13
